Sales skyrocket for weight-loss drug firm Novo Nordisk
Sales skyrocket for weight-loss drug firm Novo Nordisk
www.euronews.com Sales skyrocket for weight-loss drug firm Novo Nordisk
The Danish drugmaker expects double-digit growth to continue into 2024 as demand soars for obesity and diabetes medication.
You're viewing a single thread.
4 comments
Studies show that once you stop using this drug, the weight returns in 2/3 of the former users.
which is why sales will continue to skyrocket